ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
-0,01%
Bitcoin
63.819,62
1,48%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Cytokinetics Inc (CYTK)

  7. Cytokinetics Inc (CYTK) News

CYTK Cytokinetics Inc

65,27
0,93 (1,45%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Cytokinetics Inc CYTK NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,93 1,45% 65,27 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
66,08 65,00 66,605 65,27 64,34
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202422:00GLOBECytokinetics Announces Inducement Grants Under Nasdaq..
29.4.202422:00GLOBECytokinetics to Host Investor Event and Conference Call to..
24.4.202422:00GLOBECytokinetics to Announce First Quarter Results on May 8,..
10.4.202413:30GLOBECytokinetics Announces Three Late Breaking Clinical Trial..
05.4.202413:30GLOBECytokinetics Presents Additional 48-Week Data From..
02.4.202422:00GLOBECytokinetics Announces Inducement Grants Under Nasdaq..
01.4.202422:00GLOBECytokinetics to Participate in the 23rd Annual Needham..
25.3.202413:15GLOBECytokinetics Announces Four Upcoming Presentations at the..
07.3.202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:21EDGAR2Form 144 - Report of proposed sale of securities
05.3.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202422:00GLOBECytokinetics to Participate in March Investor Conferences
02.3.202400:47PRNUSSuper Micro Computer and Deckers Outdoor Set to Join S&P..
01.3.202422:00GLOBECytokinetics Announces Inducement Grants Under Nasdaq..
29.2.202413:30GLOBECytokinetics Joins Global Initiative to Recognize..
28.2.202413:30GLOBECytokinetics, The Mended Hearts, Inc. and WomenHeart..
27.2.202422:05EDGAR2Form 8-K - Current report
27.2.202422:00GLOBECytokinetics Reports Fourth Quarter 2023 Financial Results
14.2.202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202422:03EDGAR2Form 144 - Report of proposed sale of securities
13.2.202422:11EDGAR2Form 144 - Report of proposed sale of securities
13.2.202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202422:00GLOBECytokinetics to Announce Fourth Quarter Results on February..
06.2.202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202422:10EDGAR2Form 144 - Report of proposed sale of securities
06.2.202422:00GLOBECytokinetics to Participate in the Oppenheimer 34th Annual..
02.2.202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:38EDGAR2Form 8-K - Current report
31.1.202422:02EDGAR2Form 144 - Report of proposed sale of securities
29.1.202413:30GLOBECytokinetics Announces Recipients of Its Sixth Annual..
25.1.202413:30GLOBECytokinetics Presents New Data at CMR 2024 From FOREST-HCM, ..
22.1.202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202422:49EDGAR2Form 144 - Report of proposed sale of securities
18.1.202419:00GLOBECytokinetics Announces New Data From FOREST-HCM to be..
12.1.202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.1.202422:09EDGAR2Form 144 - Report of proposed sale of securities
12.1.202412:10IHMARKETNEWSWall Street Highlights: DocuSign Acquisition Battle, Tesla..
11.1.202419:02DJNCytokinetics Shares Slide as Novartis Reportedly Shies Away..
08.1.202419:43DJNCytokinetics Shares Jump 16% After WSJ Report of Novartis..
04.1.202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202422:02EDGAR2Form 144 - Report of proposed sale of securities
03.1.202422:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
CYTK
Cytokinetics
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten